{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:02:13Z","timestamp":1785250933913,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.vaccine.2026.128755","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:19:42Z","timestamp":1779797982000},"page":"128755","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Advancing national preparedness for the introduction of novel tuberculosis vaccines in South Africa: policy, evidence, and system readiness insights from a national workshop"],"prefix":"10.1016","volume":"86","author":[{"given":"Norbert","family":"Ndjeka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priashni","family":"Subrayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem A.","family":"Hanekom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waasila","family":"Jassat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique Kany Kany","family":"Luabeya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nkateko","family":"Mkhondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudzani","family":"Muloiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phumeza","family":"Tisile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thobani","family":"Ntshiqa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody","family":"Boffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Giersing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128755_bb0005","series-title":"Global tuberculosis report 2024","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128755_bb0010","series-title":"Global tuberculosis report 2016","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.vaccine.2026.128755_bb0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.778028","article-title":"A perspective on the success and failure of BCG","volume":"12","author":"Kumar","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.vaccine.2026.128755_bb0020","series-title":"The end TB strategy","author":"World Health Organization","year":"2015"},{"key":"10.1016\/j.vaccine.2026.128755_bb0025","series-title":"2024 Vaccines Pipeline Report","author":"Frick","year":"2024"},{"issue":"17","key":"10.1016\/j.vaccine.2026.128755_bb0030","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1803484","article-title":"Phase 2b controlled trial of M72\/AS01E vaccine to prevent tuberculosis","volume":"379","author":"Van Der Meeren","year":"2018","journal-title":"New England J. Med."},{"issue":"6","key":"10.1016\/j.vaccine.2026.128755_bb0035","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.vaccine.2024.01.072","article-title":"Modelling the health and economic impacts of M72\/AS01E vaccination and BCG-revaccination: estimates for South Africa","volume":"42","author":"Sumner","year":"2024","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.128755_bb0040","series-title":"WHO global framework to prepare for country introduction of new tuberculosis vaccines for adolescents and adults","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128755_bb0045","author":"Gavi, the Vaccine Alliance"},{"key":"10.1016\/j.vaccine.2026.128755_bb0050","series-title":"Advancing policy and decision-making for TB vaccine introduction in South Africa: a preparedness workshop","author":"South Africa National Department of Health","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128755_bb0055","series-title":"National TB recovery plan: April 2022\u2013March 2023","author":"South Africa National Department of Health","year":"2022"},{"key":"10.1016\/j.vaccine.2026.128755_bb0060","series-title":"National TB recovery plan 4.0: April 2025\u2013March 2026","author":"South Africa National Department of Health","year":"2025"},{"key":"10.1016\/j.vaccine.2026.128755_bb0065","series-title":"Vision 2008: TB strategic plan 2023\u20132028","author":"South Africa National Department of Health","year":"2024"},{"key":"10.1016\/j.vaccine.2026.128755_bb0070","author":"UN General Assembly"},{"key":"10.1016\/j.vaccine.2026.128755_bb0075","series-title":"Overview of expanded programme on immunisation in South Africa: vaccine hesitancy webinar (8 May 2024) [presentation slides]","author":"South Africa National Department of Health","year":"2024"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128755_bb0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.9745\/GHSP-D-18-00090","article-title":"Human papillomavirus vaccine introduction in South Africa: implementation lessons from an evaluation of the national school-based vaccination campaign","volume":"6","author":"Delany-Moretlwe","year":"2018","journal-title":"Glob. Health Sci. Pract."},{"key":"10.1016\/j.vaccine.2026.128755_bb0085","series-title":"South Africa COVID-19 situation report no. 21: May\u2013June 2022","author":"United Nations Children'\u2019s Fund (UNICEF)","year":"2022"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128755_bb0090","first-page":"e189","article-title":"Potential impact of tuberculosis vaccines in China, South Africa and India","volume":"20","author":"Harris","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.vaccine.2026.128755_bb0095","series-title":"WHO preferred product characteristics for new tuberculosis vaccines","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.vaccine.2026.128755_bb0100","series-title":"An investment case for new tuberculosis vaccines","author":"World Health Organization","year":"2022"},{"key":"10.1016\/j.vaccine.2026.128755_bb0105","series-title":"Catalysing solutions for equitable global access and sustainable financing for novel tuberculosis vaccines for adults and adolescents","author":"World Health Organization","year":"2025"},{"issue":"12","key":"10.1016\/j.vaccine.2026.128755_bb0110","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S1473-3099(25)00666-8","article-title":"G20 2025: advancing equity and affordability in future tuberculosis vaccines for adolescents and adults","volume":"25","author":"Ghebreyesus","year":"2025","journal-title":"Lancet Infect. Dis."},{"issue":"4","key":"10.1016\/j.vaccine.2026.128755_bb0115","article-title":"A qualitative study exploring motivators and barriers to COVID-19 vaccine uptake among adults in South Africa and Zimbabwe","volume":"11","author":"Myburgh","year":"2023","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2026.128755_bb0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s44263-024-00070-5","article-title":"\u201cThis is an illness. no one is supposed to be treated badly\u201d: community-based stigma assessments in South Africa to inform tuberculosis stigma intervention design","volume":"2","author":"Foster","year":"2024","journal-title":"BMC Glob Public Health"},{"key":"10.1016\/j.vaccine.2026.128755_bb0125","series-title":"End TB campaign 2025\/26: operational plan","author":"South Africa National Department of Health","year":"2025"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T14:40:23Z","timestamp":1785249623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26005645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":25,"alternative-id":["S0264410X26005645"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128755","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing national preparedness for the introduction of novel tuberculosis vaccines in South Africa: policy, evidence, and system readiness insights from a national workshop","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128755","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128755"}}